The CiBiD Group’s Strong home turf

The development and production of a CBD high-quality product has been the focus of the CiBiD Group from day one.

Since 2 November 2 2015, the CiBiD Group has been authorised by the Danish Medicines Agency to extract CBD oil from industrial hemp. In 2017, the CiBiD Group entered into an agreement with Medical company, where the production process is carried out and approved under GMP (Good Manufacturing Practice), which is required if it is to be used as an intermediate product (API) for drug production. This also permits export of the finished product (API) to other countries. Expected production in 2018: 600 litres Raw materials are in stock

Want to know more?